Biota Pharmaceuticals, Inc.
Biota Pharmaceuticals, Inc. (BOTA) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 31 transactions totaling $599.6K, demonstrating a bullish sentiment with $599.6K in net insider flow. The most recent transaction on Feb 9, 2016 involved a purchase of 300 shares valued at $420.
BOTA Insider Activity Summary
Who Is Buying BOTA Stock?
No significant insider buying has been recorded for BOTA in the recent period.
Who Is Selling BOTA Stock?
No significant insider selling has been recorded for BOTA in the recent period.
Is Biota Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BOTA is bullish with an Insider Alignment Score of 100/100 and a net flow of $599.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BOTA Frequently Asked Questions
Understanding BOTA Insider Activity
Insider trading at Biota Pharmaceuticals, Inc. (BOTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading BOTA stock, having executed 31 transactions in the past 90 days. The most active insider is James Fox (Executive), who has made 6 transactions totaling $325.5K.
Related Tools
Track Biota Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at BOTA file new Form 4 transactions